Segment Information (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) segment	Jun. 30, 2018 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			2
Segment Reporting Information [Line Items]
Total revenue	$ 164,705	$ 245,502	$ 269,682	$ 424,084
Interest income, net	13,361	51,809	26,574	111,402
Income (loss) from operations	(1,398,138)	(9,103,681)	(3,641,781)	(17,386,501)
Operating Segments | Consumer Operations
Segment Reporting Information [Line Items]
Total revenue	164,705	245,502	269,682	424,084
Interest income, net	0	0	0	0
Income (loss) from operations	11,821	(645,687)	(41,287)	(1,902,993)
Operating Segments | Drug Development
Segment Reporting Information [Line Items]
Total revenue	0	0	0	0
Interest income, net	0	0	0	0
Income (loss) from operations	(29,294)	(6,170,488)	(29,678)	(10,834,565)
Corporate
Segment Reporting Information [Line Items]
Total revenue	0	0	0	0
Interest income, net	13,361	51,809	26,574	111,402
Income (loss) from operations	$ (1,380,665)	$ (2,287,506)	$ (3,570,816)	$ (4,648,943)